AINewsnow

Enveda Raises $311M Series E at $2B Valuation to Advance AI-Discovered Natural Medicines

Enveda, a biotech startup that uses AI to discover new drugs from the natural world, has raised a $311 million Series E at a $2 billion valuation. The round was led by Catalio Capital Management, with participation from Iconiq and other investors, and doubles the valuation the company reached 12 mo…

Read the full story at AI Insider ↗

Timeline · 1 report

  1. 2026-09-25 14:37 · AI Insider
    Enveda Raises $311M Series E at $2B Valuation to Advance AI-Discovered Natural Medicines

More stories

  1. Introducing GPT-6 Sol and Luna — OpenAI News
  2. Gemini 3.8 text-to-speech says hello — Google Gemini Blog
  3. Introducing Gemini 3.8 Live with Live Avatar — Google Gemini Blog
  4. OpenAI ‘agent’ hacked an Australian health service website — Financial Times AI
  5. Sam Altman’s remarks at the United Nations Security Council — OpenAI News
  6. Muse AI now hands over phone calls to human agents: Meta tests new feature in its personal assistant — Mint AI
  7. Introducing Ray-Ban Meta Audio and More AI Glasses Styles — Meta Newsroom
  8. The Ezra Klein Show: Jensen Huang Thinks A.I. Alarmism Has Gone Too Far — Hard Fork (NYT)

Get the daily brief of stories like this at 6:30 every morning →